Posted
Comment Start Date
Comment Due Date
Document Type
Other
Document ID
FTC-2020-0073-0001
Ottobock seeks approval for the proposed divestiture of the FIH Group Holdings, LLC (“Freedom”) microprocessor-controlled prosthetic knee business, together with a portfolio of complementary prosthetic foot and ankle products to Proteor, Inc. (“Proteor”), as
reflected in the November 1, 2019, Commission Final Order entered in connection with In the
Matter of Otto Bock HealthCare North America, Inc., a corporation, Docket No. 9378.